Evidence map›Paper›PMID 42683481›Full record

ArticleSurgical case reports2026

Breast Cancer with Subacute Progressive Neurological Symptoms due to Anti-Yo Antibody-Associated Paraneoplastic Neurological Syndrome: A Case Report.

Moe Tasaki, Misato Okazaki, Yoshiya Horimoto, Minori Kawabata, Mariko Yoshino, Chisaki Hao, Kotaro Iijima, Yuji Tomizawa, Taku Hatano, Goro Kutomi

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Moe TasakiDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Misato OkazakiDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yoshiya HorimotoDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Minori KawabataDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Mariko YoshinoDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Chisaki HaoDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Kotaro IijimaDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yuji TomizawaDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Taku HatanoDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Goro KutomiDepartment of Breast Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnti-Yo antibody-associated paraneoplastic neurological syndrome (PNS) is a rare immune-mediated disorder that often presents with subacute cerebellar symptoms and is frequently associated with breast and gynecological malignancies. CASE PRESENTATION: A woman in her 50s developed subacute progressive neurological symptoms, including dizziness, diplopia, dysphagia, gait disturbance, ataxia, and nystagmus. Brain MRI showed no obvious abnormalities. Although Miller-Fisher syndrome was initially suspected, intravenous immunoglobulin therapy had limited efficacy, and serum anti-Yo antibodies were subsequently detected. Further investigation revealed human epidermal growth factor receptor 2-positive breast cancer with axillary lymph node metastasis. Because her neurological symptoms rapidly progressed and her performance status deteriorated, neoadjuvant chemotherapy was considered difficult. Left mastectomy with axillary lymph node dissection was therefore performed as prompt tumor-directed treatment. The final pathological stage was pT1aN1aM0, stage IIA. Postoperatively, additional immunomodulatory treatments and rehabilitation were provided for the neurological deficits.

conclusionsThis case highlights the importance of considering anti-Yo antibody-associated PNS in patients with unexplained subacute progressive neurological symptoms, even when brain imaging shows no clear abnormalities. Early recognition of PNS and prompt screening for an underlying malignancy, including breast cancer, are essential to allow timely tumor-directed treatment before severe neurological deficits become established.

Indexed as

anti-Yo antibodybreast cancerparaneoplastic neurological syndromesubacute neurological symptomstumor-directed treatment

Identifiers

PMID42683481
PMCPMC13533599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.